about
Genetical genomic determinants of alcohol consumption in rats and humansEffectiveness of skills-based training using the Drink-less package to increase family practitioner confidence in intervening for alcohol use disorders.Better methods to collect self-reported alcohol and other drug use data from Aboriginal and Torres Strait Islander Australians.The relationship between self-reported alcohol intake and the morbidities managed by GPs in AustraliaThe effects of alcohol consumption, psychological distress and smoking status on emergency department presentations in New South Wales, Australia.Using breath carbon monoxide to validate self-reported tobacco smoking in remote Australian Indigenous communities.Harm reduction healthcare: from an alternative to the mainstream platform?HIV awareness of outgoing female migrant workers of Bangladesh: a pilot study.Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men.The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: a narrative synthesis of literature.Primary healthcare outlets that target injecting drug users: opportunity to make services accessible and acceptable to the target group.Increasing prevalence of HIV, and persistent high-risk behaviours among drug users in Bangladesh: need for a comprehensive harm reduction programme.Client satisfaction and risk behaviours of the users of syringe dispensing machines: a pilot study.HIV and sexual risk behaviors among recognized high-risk groups in Bangladesh: need for a comprehensive prevention program.Validation of the Bayesian Alcoholism Test compared to single biomarkers in detecting harmful drinking.Alcohol use in China.Traditional markers of excessive alcohol use.Alcohol for the prevention of type 2 diabetes mellitus?Translation of tobacco policy into practice in disadvantaged and marginalized subpopulations: a study of challenges and opportunities in remote Australian Indigenous communities.Assessing the role of syringe dispensing machines and mobile van outlets in reaching hard-to-reach and high-risk groups of injecting drug users (IDUs): a reviewThe effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings.Forming a national multicentre collaboration to conduct clinical trials: increasing high-quality research in the drug and alcohol field.Sexually transmitted infections, sexual risk behaviours and perceived barriers to safe sex among drug users.Smoking or alcohol dependence among Indigenous Australians: treatment may be needed, not just education.Managing confidentiality in illicit drugs research: ethical and legal lessons from studies in remote Aboriginal communities.Can we measure daily tobacco consumption in remote indigenous communities? Comparing self-reported tobacco consumption with community-level estimates in an Arnhem Land study.Promising performance of a juvenile justice diversion programme in remote Aboriginal communities, Northern Territory, Australia.Five-year longitudinal study of cannabis users in three remote Aboriginal communities in Arnhem Land, Northern Territory, Australia.Evaluation of a community-driven preventive youth initiative in Arnhem Land, Northern Territory, Australia.Opioid substitution therapy clients' preferences for targeted versus general primary health-care outlets.Improving services for prevention and treatment of substance misuse for Aboriginal communities in a Sydney Area Health Service.The role of an Aboriginal women's group in meeting the high needs of clients attending outpatient alcohol and other drug treatment.Extent of alcohol prohibition in civil policy in Muslim majority countries: the impact of globalization.Mind the gap: What is the difference between alcohol treatment need and access for Aboriginal and Torres Strait Islander Australians?Characteristics and comorbidity of drug and alcohol-related emergency department presentations detected by nursing triage text.Detection of and intervention for excessive alcohol and tobacco use among adult hospital in-patients.The long-term effectiveness of brief interventions for unsafe alcohol consumption: a 10-year follow-up.Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment.Assessment of alcohol consumption among hepatitis C-positive people receiving opioid maintenance treatment using direct ethanol metabolites and self-report: a pilot study.Self-perceived problem with alcohol use among opioid substitution treatment clients.
P50
Q21245326-9C524556-C8D7-4EF1-B6AE-89BD19962B5AQ25257641-4F2D4785-5AA4-4F72-9141-0CD327ADB146Q30825193-BF6298D1-8D3E-421D-A918-FB5B8BE6A482Q33236450-7D108691-7A0D-478D-84CC-339EC6E0D6FFQ33281064-FFF493F8-8626-47BD-93E9-BCBC6FB03300Q33705558-E6A61BAE-540C-4581-BC4B-CD333755823CQ34094111-2347137C-A610-42B9-AE9F-0A1C73D90735Q34098716-700E8C1D-E09F-4F1D-9DE3-E00236512AA0Q34169470-2E5694C1-54FE-4183-A2A8-09C3D78C1FC9Q34223975-D6287CBF-ACA5-4B78-B2ED-6D66BF8CCB31Q34249917-9FD73762-5032-455A-883E-BB5B4469A1E3Q34636855-5CF54148-2C18-409D-A6BE-B18857BEB8E1Q34717800-914B87C9-E277-41B4-84D3-B5C1A6D4D051Q34759662-160A5ED1-3E4D-4585-AD17-2920A64DE223Q35067210-7A1B3569-3FCB-48AD-A44E-436D021C7BFEQ35591393-482B266C-E8FE-4703-ACBF-5B39BF4E1231Q35675680-337663C4-0475-4E7D-A381-D857C3109405Q36168201-9C765275-33DD-4CB8-B754-0D89F9DBB299Q36243950-B70722EE-CB78-4400-90D6-E4DB822AF01CQ36285894-E8DE9DAD-7E4E-4C72-BB2E-148E0A18DDACQ36927156-FBA9C43C-5D46-4470-A17F-30F00BCBD968Q37795929-275EF3C9-76AB-4736-8957-6E4682D511CFQ37846153-24595252-77DC-4768-B815-9B3669D00E32Q38028107-FFC1DC0E-472D-4DBF-89DD-529791DA6CA2Q38949063-F6EB4B61-74EF-4048-B031-9AEA2EA8EAE7Q38949077-39BEA615-9040-45D2-A2AC-D1320D706496Q38949079-ACDE1363-2534-4FF3-9F22-330596A0C06AQ39167017-CEBD1584-B3B8-4CEA-BAF0-AC145B13CC5EQ39274323-09F701ED-649F-484E-86C3-6D71F30580E9Q39562866-784C90E5-0D70-4F3F-AF1F-A2156437D341Q39833851-5FBD85CC-F588-451D-B22D-0CE7AC653187Q40132468-9F0985FE-DF03-436B-AC4F-0FE9332FB0A0Q40385247-E75A1B37-8191-4202-B2DD-93C5C7A17AA5Q40582774-4DF6A1E5-6DB9-4A0B-A85A-50383598EE9EQ43165502-8DC9E42A-CD1A-4DEF-A7DD-B14DD026AF18Q43779921-17A33F0E-8CD2-4C63-B89C-A33909299FA3Q44041486-C075C2C4-0390-43DB-817D-2AE0568CE2AFQ44334824-12569B17-12BB-470B-BEEB-AA949D966A70Q44336024-53E5BF7A-7B92-4C26-B3A5-875B14FDAF93Q44337891-E3ED13AF-CE40-4F1C-8AF2-B8D26BF56A4A
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Katherine M. Conigrave
@ast
Katherine M. Conigrave
@en
Katherine M. Conigrave
@es
Katherine M. Conigrave
@nl
Katherine M. Conigrave
@sl
type
label
Katherine M. Conigrave
@ast
Katherine M. Conigrave
@en
Katherine M. Conigrave
@es
Katherine M. Conigrave
@nl
Katherine M. Conigrave
@sl
altLabel
Kate Conigrave
@en
prefLabel
Katherine M. Conigrave
@ast
Katherine M. Conigrave
@en
Katherine M. Conigrave
@es
Katherine M. Conigrave
@nl
Katherine M. Conigrave
@sl
P106
P1153
7004097569
P21
P31
P496
0000-0002-6428-1441